FrancophonIA/ELRC3.0 huggingface dataset:
Latvian: Šajos pētījumos pacienti lietoja iekšķīgas vai intranazālas zāļu formas, taču ticams, ka risks palielinās arī subkutānas, intramuskulāras un intravenozas kalcitonīna lietošanas, īpaši ilgstošas terapijas, gadījumā, jo sagaidāms, ka kalcitonīna kopējā sistēmiskā iedarbība šādiem pacientiem ir lielāka nekā citu zāļu formu lietotājiem.
Icelandic: Sjúklingar í þessum rannsóknum fengu meðferð með lyfjaformum til inntöku eða til notkunar í nef en hins vegar er líklegt að aukin áhætta eigi einnig við þegar calcitonin er gefið undir húð, í vöðva eða í bláæð, sérstaklega við langvarandi notkun, vegna þess að búist er við að altæk útsetning fyrir calcitonini hjá slíkum sjúklingum sé meiri en við notkun annarra lyfjaforma.
Latvian: Ieteicamais terapijas ilgums ir divas nedēļas, un tas nekādā gadījumā nedrīkst pārsniegt četras nedēļas, jo ilgstoša kalcitonīna lietošana ir saistīta ar palielinātu ļaundabīgu audzēju risku.
Icelandic: Ráðlagður meðferðartími er 2 vikur og skal ekki í nokkru tilviki vera lengri en 4 vikur, vegna tengsla milli aukinnar hættu á illkynja sjúkdómum og langvarandi notkunar calcitonins.
Latvian: Pedžeta slimība
Icelandic: Pagetssjúkdómur
Latvian: Šiem pacientiem periodiski var apsvērt atkārtotu ārstēšanu, ņemot vērā iespējamos ieguvumus un pierādījumus par palielinātu ļaundabīgu audzēju risku ilgstošas kalcitonīna lietošanas gadījumā (skatīt 4.4. apakšpunktu).
Icelandic: Íhuga má lotubundna endurmeðferð hjá þessum sjúklingum og taka skal tillit til hugsanlegs ávinnings og tengsla milli aukinnar hættu á illkynja sjúkdómum og langvarandi notkunar calcitonins (sjá kafla 4.4).
Latvian: Pedžeta slimības terapija tikai pacientiem, kas nereaģē pret citiem pieejamiem terapijas līdzekļiem vai kuriem tie nav piemēroti, piemēram, pacientiem ar smagiem nieru darbības traucējumiem.
Icelandic: Til meðferðar við Pagetssjúkdómi, eingöngu hjá sjúklingum sem ekki svara annarri meðferð eða sem hentar ekki önnur meðferð, til dæmis þeim sem eru með verulega skerta nýrnastarfsemi.
Latvian: Šajos pētījumos pacientiem kalcitonīna grupā tika atklāta vēža absolūtā riska palielināšanās, salīdzinot ar placebo grupu, un palielinājums svārstījās no 0,7% līdz 2,4% ilgstošas terapijas gadījumā.
Icelandic: Þessar rannsóknir sýndu að aukning raunáhættu fyrir krabbameini hjá sjúklingum, sem fengu meðferð með calcitonini samanborið við þá sem fengu lyfleysu, var á bilinu 0,7% til 2,4% við langvarandi meðferð.
Latvian: Ārstēšanas ilgums parasti nedrīkst pārsniegt trīs mēnešus, jo iegūti pierādījumi par palielinātu ļaundabīgu audzēju risku ilgstošas kalcitonīna lietošanas gadījumā.
Icelandic: Meðferðin skal venjulega ekki vara lengur en í 3 mánuði vegna vísbendinga um aukinnar hættu á illkynja sjúkdómum og langvarandi notkunar calcitonins.
Latvian: Iespējamās blakusparādības [jāievieto turpmāk norādītais teksts]
Icelandic: Hugsanlegar aukaverkanir [bæta skal við textanum hér að neðan]
Latvian: [pašlaik reģistrētās indikācijas ir jāizdzēš un jāaizstāj ar šādu tekstu]
Icelandic: [eyða skal út samþykktum texta og setja eftirfarandi texta inn í staðinn]
Latvian: kaulaudu zuduma novēršanai: pa 100 SV dienā vai pa 50 SV divas reizes dienā 2 - 4 nedēļas ilgi, zāles ievadot muskulī vai zemādas audos;
Icelandic: 100 a.e. á dag eða 50 a.e. tvisvar sinnum á dag í 2 til 4 vikur, gefið í vöðva eða í vefinn rétt undir húðinni.
Latvian: Ļaundabīgi audzēji (ilgstošas terapijas gadījumā), biežuma grupa: bieži
Icelandic: Illkynja sjúkdómur (við langvarandi notkun), tíðni: algengar
Latvian: Deva jāpielāgo pacienta individuālajām vajadzībām.
Icelandic: Aðlaga þarf skammta að þörfum hvers sjúklings.
Latvian: 4.8 Nevēlamās blakusparādības [jāievieto turpmāk norādītais teksts]
Icelandic: 4.8 Aukaverkanir [bæta skal við textanum hér að neðan]
Latvian: Pedžeta slimība ir lēni progresējoša slimība, kas var izraisīt noteiktu kaulu lieluma un formas izmaiņas; - vēža izraisīta augsta kalcija līmeņa asinīs (hiperkalciēmijas) ārstēšanai.
Icelandic: Pagetssjúkdómur er hægt versnandi sjúkdómur sem getur leitt til breytinga á stærð og lögun ákveðinna beina.
Latvian: 4.4 Īpaši brīdinājumi un piesardzība lietošanā [jāievieto turpmāk norādītais teksts]
Icelandic: 4.4 Sérstök varnaðarorð og varúðarreglur við notkun [bæta skal við textanum hér að neðan]
Latvian: Analizējot nejaušinātus kontrolētus pētījumus, kuros piedalījās pacienti ar osteoartrītu un osteoporozi, tika pierādīts, ka kalcitonīns ir saistīts ar statistiski nozīmīgu vēža riska palielināšanos, salīdzinot ar pacientiem placebo grupā.
Icelandic: Greiningar á slembuðum samanburðarrannsóknum sem gerðar voru hjá sjúklingum með slitgigt og beinþynningu, hafa sýnt að calcitonin tengist tölfræðilega marktækt aukinni hættu á krabbameini samanborið við sjúklinga sem fengu lyfleysu.
Latvian: Klīniskos pētījumos pacientiem, kas kalcitonīnu lietoja osteoartrīta vai osteoporozes ārstēšanai, pēc ilgstošas tā lietošanas bija palielināts vēža risks.
Icelandic: Í klínískum rannsóknum hjá sjúklingum á meðferð með calcitonini við beinþynningu og slitgigt kom fram aukin hætta á krabbameini eftir langvarandi meðferð.
Latvian: Ļaundabīgu audzēju izraisītas hiperkalciēmijas terapija.
Icelandic: Meðferð við blóðkalsíumhækkun vegna illkynja sjúkdóma.
Latvian: 4.2 Devas un lietošanas veids [jāievieto turpmāk norādītais teksts]
Icelandic: 4.2 Skammtar og lyfjagjöf [bæta skal við textanum hér að neðan]
Latvian: Pedžeta slimības ārstēšanai: pa 100 SV dienā, injicējot zāles muskulī vai zemādas audos, parasti līdz trīs mēnešiem ilgi.
Icelandic: 100 a.e. á dag gefið í vöðva eða í vefinn rétt undir húðinni, venjulega í allt að 3 mánuði.
Latvian: Tādi ir, piemēram, pacienti, kuriem lūzuma dēļ jāievēro gultas režīms; - kaulu Pedžeta slimības ārstēšanai pacientiem, kas nevar lietot citas zāles šīs slimības ārstēšanai, piemēram, pacientiem ar nopietniem nieru darbības traucējumiem.
Icelandic: - Pagetssjúkdómi í beinum hjá sjúklingum sem hentar ekki önnur meðferð við sjúkdómnum, til dæmis sjúklingar með alvarlega nýrnasjúkdóma.
Latvian: augsta kalcija līmeņa ārstēšanai: pa 100 SV ik pēc 6 - 8 stundām, zāles ievadot muskulī vai zemādas audos.
Icelandic: 100 a.e. á 6 til 8 klst. fresti, gefið í vöðva eða í vefinn rétt undir húðinni.
Latvian: Ieteicamā deva ir 100 SV dienā subkutāni vai intramuskulāri, taču klīnisks un bioķīmisks uzlabojums panākts arī ar minimālo dozēšanas shēmu pa 50 SV trīs reizes nedēļā.
Icelandic: á dag, gefinn undir húð eða í vöðva, en hins vegar hefur lágskammtameðferð með 50 a.e. þrisvar sinnum í viku leitt til klínísks og lífefnafræðilegs bata.
Latvian: Kā lietot <piešķirtais nosaukums> [jāievieto turpmāk norādītais teksts]
Icelandic: Hvernig nota á <sérheiti> [bæta skal við textanum hér að neðan]
Latvian: Kas jāzina pirms <piešķirtais nosaukums> lietošanas [jāievieto turpmāk norādītais teksts]
Icelandic: Áður en byrjað er að nota <sérheiti> [bæta skal við textanum hér að neðan]
Latvian: Ieteicamā deva ir 100 SV dienā vai pa 50 SV divas reizes dienā subkutāni vai intramuskulāri.
Icelandic: Ráðlagður skammtur er 100 a.e. daglega eða 50 a.e. tvisvar á dag, gefinn undir húð eða í vöðva.
Latvian: Lietošanas instrukcija
Icelandic: Fylgiseðill
Latvian: 183 11 Täby Zviedrija
Icelandic: 183 11 Täby Sweden
Latvian: 75014 Paris - Francija
Icelandic: 75014 Paris - France
Latvian: 0401 Oslo, Norvēģija
Icelandic: 0401 Oslo, Norway
Latvian: 1800 Vilvoorde Beļģija
Icelandic: 1800 Vilvoorde Belgium
Latvian: 140 00 Čehija
Icelandic: 140 00 Czech Republic
Latvian: Parque Empresarial San Fernando San Fernando de Henares Madrid 28830 Spānija
Icelandic: Parque Empresarial San Fernando San Fernando de Henares Madrid 28830 spain
Latvian: PHARMACEUTICALS SA EVROU 4 AND MESSINIAS 2
Icelandic: EVROU 4 AND MESSINIAS
Latvian: Cediat Mediffusion 11 bis rue du Colisée 75008 Paris - Francija
Icelandic: Cediat Mediffusion 11 bis rue du Colisée 75008 Paris - France
Latvian: 5 D-27472 Cuxhaven Vācija
Icelandic: 5 D-27472 Cuxhaven Germany
Latvian: 425 Irakliou Avenue, 14122 Atena, Grieķija
Icelandic: 425 Irakliou Avenue, 14122 Atena, Grecia
Latvian: Avenida do Forte, 3Edificio Suécia III, Piso 1
Icelandic: Avenida do Forte, 3 - Edificio Suécia III,
Latvian: 2794-093 Carnaxide Portugāle
Icelandic: 2794-093 Carnaxide Portugal
Latvian: Calcitonine Sandoz
Icelandic: CALCITONINA SANDOZ
Latvian: Edifício 7 - 3º Piso 2740-244 Porto Salvo Portugāle
Icelandic: Edifício 7 - 3º Piso 2740-244 Porto Salvo Portugal
Latvian: Brno Čehija
Icelandic: Brno Czech Republic
Latvian: 61118 Bad Vilbel, Vācija
Icelandic: 61118 Bad Vilbel, Germany
Latvian: MEDHEL HELLAS PHARMACEUTICAL INDUSTRY
Icelandic: MEDHEL HELLAS PHARMACEUTICAL
Latvian: NOVARTIS FARMA SPA Largo Umberto Boccioni, 1 21040 OriggioVARESE
Icelandic: NOVARTIS FARMA SPA Largo Umberto Boccioni, 1 21040 Origgio
Latvian: PHARMACEUTICALS 1ST KM PAIANIASMARKOPOULOU AVENUE PAIANIA 19002
Icelandic: DOCTUM PHARMACEUTICALS 1ST KM PAIANIASMARKOPOULOU AVENUE PAIANIA 19002
Latvian: 12th Km National Highway
Icelandic: A.E.B.E. 12th Km National Highway
Latvian: D.
Icelandic: S.
Latvian: Rua Alfredo da Silva, 16 2610-016 Amadora Portugāle
Icelandic: Rua Alfredo da Silva, 16 2610-016
Latvian: 15 D-06796 Brehna Vācija
Icelandic: D-06796 Brehna Germany
Latvian: SANOFI AVENTIS, S.A.Josep Plá, 2 Barcelona 08019 SPĀNIJA
Icelandic: SANOFI AVENTIS, S.A.Josep Plá, 2 Barcelona 08019
Latvian: ALPHA GENERICS THERAPY AEBEF KORYTSAS 13
Icelandic: ALPHA GENERICS THERAPY AEBEF
Latvian: Novartis Pharma GmbH Stella-Klein-Löw-Weg 17 A-1020 Wien, Austrija
Icelandic: Novartis Pharma GmbH Stella-Klein-Löw-Weg 17 A-1020 Wien, Austria
Latvian: VOTANIA SA PEGASSOU 18
Icelandic: PEGASSOU 18
Latvian: FARMEDIA SA ATHINAS 22 AND APOLLONOS GERAKAS ATTIKIS
Icelandic: FARMEDIA SA ATHINAS 22 AND APOLLONOS
Latvian: D-83607 Holzkirchen Vācija
Icelandic: D-83607 Holzkirchen Germany
Latvian: PHARMACEUTICALS SA GOUNARI 150, GLYFADA 16674
Icelandic: GOUNARI 150, GLYFADA 16674
Latvian: Novartis Pharma SAS 2-4 rue Lionel Terray 92500 Rueil-MalmaisonFrancija
Icelandic: Novartis Pharma SAS 2-4 rue Lionel Terray 92500 Rueil-MalmaisonFrance
Latvian: ANFARM HELLAS PERIKLEOUS 53-57 ATHENS
Icelandic: ANFARM HELLAS PERIKLEOUS 53-57
Latvian: D-22946 Trittau Vācija
Icelandic: D-22946 Trittau Germany
Latvian: LEOVAN M. LEON AND CO
Icelandic: LEOVAN M. LEON AND CO MENANDROU 54
Latvian: Slovākija ratiopharm International GmbH
Icelandic: Slóvakía ratiopharm International GmbH
Latvian: Wincentego st. Pola 21 58-500, Jelenia Góra, Polija
Icelandic: 58-500, Jelenia Góra, Poland
Latvian: MEDIMAR SA MEDICINES COSMETICS KIFISSIAS 13
Icelandic: MEDIMAR SA MEDICINES COSMETICS
Latvian: Przedsiębiorstwo Farmaceutyczne Jelfa S.A.
Icelandic: Przedsiębiorstwo Farmaceutyczne Jelfa S.A. Wincentego st.
Latvian: 18th km Athens-Lamia National Road 146 71 Nea Erythrea Grieķija
Icelandic: Vianex SA, Tatoiou street, 18th km Athens-Lamia National Road 146 71 Nea Erythrea Greece
Latvian: PHARM LTD ARKOLEON 11
Icelandic: J.A. PHARM LTD ARKOLEON 11
Latvian: Čehija
Icelandic: Czech republic
Latvian: LABORATORIO PADRO, S.A.Gran Via de les Corts Catalanes, 764 barcelona 08013 Spānija
Icelandic: LABORATORIO PADRO, S.A.Gran Via de les Corts Catalanes, 764 barcelona 08013 Spain
Latvian: Novartis Healthcare A/S, Lyngbyvej 172, DK2100, København Ø, Dānija
Icelandic: Novartis Healthcare A/S, Lyngbyvej 172, DK-2100, København Ø, Denmark
Latvian: Calcitonin-ratiopharm Nasenspray
Icelandic: Calcitoninratiopharm Nasenspray
Latvian: 635 00 Brno Čehija
Icelandic: 635 00 Brno
Latvian: Calcitonin-ratiopharm 100 I.E.
Icelandic: Calcitoninratiopharm 100 I.E.
Latvian: Zambon France 13 rue René Jacques 92138 Issy les Moulineaux CedexFrancija
Icelandic: Zambon France 13 rue René Jacques 92138
Latvian: Novartis Healthcare A/S, Lyngbyvej 172, DK-2100 Østerbro, Dānija
Icelandic: Novartis Healthcare A/S, Lyngbyvej 172, DK-2100 Østerbro, Denmark
Latvian: LABORATORIO ITALIANO BIOCHIMICO FARMACEUTICO LISAPHARMA Via Licinio, 11
Icelandic: LABORATORIO ITALIANO BIOCHIMICO FARMACEUTICO LISAPHARMA
Latvian: D-89079 Ulm Vācija
Icelandic: D-89079 Ulm Germany
Latvian: Vācija mibe GmbH Arzneimittel Münchener Str.
Icelandic: Þýskaland mibe GmbH Arzneimittel Münchener Str. 15
Latvian: Calcitonin-ratiopharm 200 Nasal
Icelandic: Calcitoninratiopharm 200 Nasal
Latvian: 92300 Levallois-PerretFrancija
Icelandic: Levallois-PerretFrance
Latvian: Novartis Finland Oy Metsänneidonkuja 10 02130 Espoo Somija
Icelandic: Oy Metsänneidonkuja 10 02130
Latvian: Laboratoire Pharmy II Strategy center 26 rue des Gaudines 78100 Saint Germain en Laye - Francija
Icelandic: II Strategy center 26 rue des Gaudines 78100
Latvian: José MalhoaEdifício Malhoa Plaza nº piso-escritório 2.2 1070-325 Lisboa Portugāle
Icelandic: José Malhoa - Edifício Malhoa Plaza nº 2, piso-escritório 2.2
Latvian: ALMIRALL, S.A.Ronda General Mitre, 151
Icelandic: ALMIRALL, S.A.Ronda General Mitre, 151 08022 Barcelona
Latvian: 200IU in 1ml
Icelandic: 200 a.e. in 1ml
Latvian: EVAGGELOS KALOFOLIAS IAPHARM MENANDROU 54
Icelandic: EVAGGELOS KALOFOLIAS IAPHARM
Latvian: Lagoas Park, Edifício 10
Icelandic: Laboratórios Pfizer, Lda. Lagoas Park, Edifício 10
Latvian: Solução para Pulverização Nasal
Icelandic: UI solución para pulverización nasal
Latvian: FARMACEUTICA, S.A.Gran Via de les Corts Catalanes, 764 Barcelona 08013 Spānija
Icelandic: NOVARTIS FARMACEUTICA, S.A.Gran Via de les Corts Catalanes, 764 Barcelona 08013
Latvian: D-90429 Nürnberg, Vācija
Icelandic: D-90429 Nürnberg, Germany
Latvian: ROTTAPHARM HELLAS ACHAIAS AND TRIZOINIAS NEA KIFISSIA 14564
Icelandic: HELLAS ACHAIAS AND TRIZOINIAS NEA KIFISSIA 14564
Latvian: Raapopseweg 1
Icelandic: Piso 1
Latvian: 41 Chalton street, London, NW1 1JD, Lielbritānija
Icelandic: VERISFIELD (UK) LTD, U.K. 41 Chalton street, London, NW1 1JD, United Kingdom
Latvian: D-90429 Nürnberg Vācija
Icelandic: D-90429 Nürnberg Germany
Latvian: ESPECIALIDADES FARMACEUTICAS CENTRUM, S.A Sagitario, 14 03006 Alicante
Icelandic: ESPECIALIDADES FARMACEUTICAS CENTRUM, S.A Sagitario, 14
Latvian: PHARMACEUTICALS SA KIFISSOU AVENUE 122 PERISTERI 1231
Icelandic: KIFISSOU AVENUE 122 PERISTERI 1231
Latvian: ALFA WASSERMANN, S.P.A.Via Enrico Fermi, 1 Alanno Scalo (Pescaro) 65020 ITĀLIJA
Icelandic: ALFA WASSERMANN, S.P.A.Via Enrico Fermi, 1 Alanno Scalo (Pescaro) 65020 ITALIA
Latvian: Itālija
Icelandic: Italy
Latvian: Gentsesteenweg 615 1080 Brussels Beļģija
Icelandic: Nycomed Belgium sca/cva Gentsesteenweg 615 1080 Brussels Belgium
Latvian: UCB Pharma GmbH Geiselbergstraße 1719/2, 5.Stock 1110 Wien, Austrija
Icelandic: UCB Pharma GmbH Geiselbergstraße 17-19/2, 5.Stock
Latvian: I pielikums Zāļu nosaukumi, zāļu formas, stiprumi, lietošanas veidi, reģistrācijas apliecības īpašnieki dalībvalstīs
Icelandic: Viðauki I Listi yfir heiti, lyfjaform, styrkleika lyfsins/lyfjanna, íkomuleið(ir), markaðsleyfishafa í aðildarlöndunum
Latvian: 200 I.U./dose, 2000 I.U./ML
Icelandic: 200 a.e./skammt, 2000 a.e./ML
Latvian: PIKERMI ATTIKIS 19009
Icelandic: MARATHONOS AVENUE 95 PIKERMI ATTIKIS 19009
Latvian: PHARMANEL LTD MARATHONOS 106 GERAKAS ATTIKIS
Icelandic: PHARMANEL LTD MARATHONOS 106
Latvian: Novartis FarmaProdutos Farmacêuticos, S.A.
Icelandic: Novartis Farma - Produtos Farmacêuticos, S.A.
Latvian: Miacalcic Nasal 100 100 IU
Icelandic: Miacalcic Nasal 100 100 a.e.
Latvian: 200 U.I./dose šķīdums izsmidzināšanai
Icelandic: 200 a.e./skammt Lausn fyrir eimgjafa
Latvian: Calcitonin 'Novartis'
Icelandic: Calcitonin 'Novartis' 200 I.E.
Latvian: Ratiopharm GmbH Graf-Arco-Str.
Icelandic: Ratiopharm GmbH Graf-Arco-Str. 3., Ulm
Latvian: Alfa Wassermann S.p.A. Via Enrico Fermi, 1 65020 - Alanno (Pescara)
Icelandic: Alfa Wassermann S.p.A. Via Enrico Fermi, 1 65020 - Alanno (Pescara) Italy
Latvian: Frimley Business Park, Frimley Camberley, Surrey GU16 7SR, Lielbritānija
Icelandic: Frimley Business Park, Frimley Camberley, Surrey GU16 7SR, United Kingdom
Latvian: KIFISSIAS AVENUE 196, HALANDRI 15232
Icelandic: NYCOMED HELLAS S.A. KIFISSIAS AVENUE 196, HALANDRI 15232
Latvian: MARATHONOS AVENUE
Icelandic: KM ATHENS-LAVRION AVENUE
Latvian: VOCATE
Icelandic: VOTANIA SA
Latvian: KIFISSIAS AVENUE 196, HALANDRI 15231
Icelandic: NYCOMED HELLAS S.A. KIFISSIAS AVENUE 196, HALANDRI 15231
Latvian: João II, Torre Fernão de Magalhães10 Esqº
Icelandic: Av. D. João II, Torre Fernão de Magalhães - 10 Esqº 1998-025 Lisboa
Latvian: Pharmaceuticals Uk Ltd, Frimley Business Park, Frimley, Camberley, Surrey, Lielbritānija
Icelandic: Novartis Pharmaceuticals Uk Ltd, Frimley Business Park, Frimley, Camberley, Surrey, UK
Latvian: ATHENS 17671
Icelandic: ACHARNES 13671
Latvian: Osseocalcina 200
Icelandic: TONOCALTIN 200
Latvian: Miacalcic 50 IU/1 ml
Icelandic: Miacalcic 50 IU/1 ml 50 a.e./1 ml
Latvian: PHARMACEUTICALS FYLIS AVENUE 137, KAMATERO 13453
Icelandic: IASIS PHARMACEUTICALS FYLIS AVENUE 137, KAMATERO 13453
Latvian: PHARMACEUTICALS FYLIS AVENUE 137, KAMATERO 13452
Icelandic: IASIS PHARMACEUTICALS FYLIS AVENUE 137, KAMATERO 13452
Latvian: BALU COMMERCE OF PARAPHARMACEUTICALS AND COSMETICS 30TH KM ATHENSLAVRION AVENUE MARKOPOULO 19003
Icelandic: BALU COMMERCE OF PARAPHARMACEUTICALS AND COSMETICS 30TH
Latvian: NOVARTIS PHARMA GmbH,Roonstrasse 25D90429 Nürnberg, Vācija
Icelandic: NOVARTIS PHARMA GmbH,Roonstrasse 25D90429 Nürnberg, Germania
Latvian: Rua do Centro Empresarial, Edifício 8, Quinta da Beloura
Icelandic: Laboratório NormalProdutos Farmacêuticos, S.A. Rua do Centro Empresarial, Edifício 8, Quinta da Beloura 2710-444 Sintra Portugal
Latvian: PHARMACEUTICALS FYLIS AVENUE 137, KAMATERO 13451
Icelandic: IASIS PHARMACEUTICALS FYLIS AVENUE 137, KAMATERO 13451
Latvian: Sanofi - Produtos Farmacêuticos, Lda.
Icelandic: Sanofi - Produtos Farmacêuticos, Lda. Empreendimento Lagoas Park,
Latvian: GABRIEL HEALTH PHARMACEUTICALS LTD GRIG.
Icelandic: PHARMACEUTICALS LTD GRIG.
Latvian: PHARMACEUTICAL INDUSTRY
Icelandic: Laboratoire Pharmy
Latvian: Pharmaceuticals UK Limited, Frimley Business Park, Frimley, Camberley, Surrey GU16 7SR
Icelandic: Novartis Pharmaceuticals UK Limited, Frimley Business Park, Frimley, Camberley, Surrey GU16 7SR
Latvian: Stiprums Zāļu forma
Icelandic: Styrkur Lyfjaform
Latvian: Iepakojuma lielumi
Icelandic: Pakkningarstærð
Latvian: Tiešais iepakojums
Icelandic: Pakkning
Latvian: (ES) numurs
Icelandic: EU Númer
Latvian: • vienu reizi dienā,
Icelandic: ● einu sinni á hverjum degi
Latvian: • apmēram 1 stundas laikā.
Icelandic: ● á um það bil 1 klukkustund
Latvian: Ārsts uzraudzīs kā zāles Jums iedarbojas.
Icelandic: Læknirinn mun fylgjast með hversu vel lyfið verkar á þig.
Latvian: Ir ierobežoti dati par drošību terapijai, kas ilgst vairāk par 4 nedēļām.
Icelandic: Upplýsingar eru takmarkaðar um öryggi meðferðar sem varir lengur en 4 vikur.
Latvian: Lūdziet savam ārstam papildu informāciju.
Icelandic: Spyrðu lækninn um frekari upplýsingar.
Latvian: Bērni (no 12 mēnešu līdz 17 gadu vecumam)
Icelandic: Börn (12 mánaða til 17 ára)
Latvian: Nav zināmi (nevar noteikt pēc pieejamiem datiem)
Icelandic: Tíðni ekki þekkt (ekki hægt að áætla tíðni útfrá fyrirliggjandi gögnum)
Latvian: Visumā pieaugums bija neliels un nebija pietiekams, lai mainītu devas.
Icelandic: Almennt var aukningin lítil og ekki nógu mikil til að þörf væri á aðlögun skammta.
Latvian: Šajā pētījumā iesaistīto pacientu ar neitropēniju skaits arī bija ierobežots (8,0%).
Icelandic: Fjöldi sjúklinga með daufkyrningafæð var einnig takmarkaður í þessa rannsókn (8,0%).
Latvian: Derīguma termiņs attiecas uz norādītā mēneša pēdējo dienu.
Icelandic: Fyrningardagsetning er síðasti dagur mánaðarins sem þar kemur fram.
Latvian: Slikto iesaistes rādītāju dēļ pētījumu pārtrauca agrīni, un tika randomizēts tikai 51 pacients.
Icelandic: Vegna lélegrar þátttöku var rannsóknin stöðvuð snemma og aðeins 51 sjúklingi var slembiraðað.
Latvian: • Jums kādreiz ir bijušas veselības problēmas.
Icelandic: ● ef þú hefur einhvern tíma átt við einhver önnur heilsufarsvandamál að stríða.
Latvian: Vidējais terapijas ilgums bija 33,7 dienas, diapazonā no 1 līdz 162 dienām.
Icelandic: Meðallengd meðferðar var 33,7 dagar, frá 1 til 162 dagar.
Latvian: Tas ir tāpēc, ka to sastāvā nav konservantu, kas aptur baktēriju augšanu.
Icelandic: Það er vegna þess að það inniheldur engin efni sem koma í veg fyrir bakteríuvöxt.
Latvian: 70 mg (no diviem 50 mg flakoniem) **
Icelandic: 70 mg (úr tveimur 50 mg hettuglösum)**
Latvian: Ja tas rodas, jāpārtrauc lietot kaspofungīnu un jāsāk atbilstoša terapija.
Icelandic: Ef slíkt kemur fram á að hætta gjöf caspófúngíns og hefja viðeigandi meðferð.
Latvian: Tāpat kā lietojot citas recepšu zāles, dažas blakusparādības var būt nopietnas.
Icelandic: Eins og á við um um önnur lyfseðilsskyld lyf geta sumar aukaverkanir verið alvarlegar.
Latvian: Šajā pētījumā kaspofungīna deva tika ievadīta vairāk nekā 2 stundu laikā (parasti 1 stundu ilgās ievadīšanas vietā).
Icelandic: Í þessari rannsókn var caspófúngín skammturinn gefinn á 2 klukkustundum (í stað venjulegrar einnar klukkustundar gjafar).
Latvian: Izvadīšana notiek lēni, un galīgais radioaktivitātes pusizvades periods bija 12 līdz 15 dienas.
Icelandic: Útskilnaður er hægur og helmingun geislavirkni tók 12 til 15 daga.
Latvian: Cancidas Jums tiks ievadīta:
Icelandic: Þér verður gefið Cancidas:
Latvian: Šie gadījumi neizraisīja klīniski nozīmīgas blakusparādības.
Icelandic: Þessi atburður hafði ekki klínískt mikilvægar aukaverkanir í för með sér.
Latvian: Pētījumi in vitro liecina, ka kaspofungīns nedarbojas kā citohromālo enzīmu P450 1A2, 2A6, 2C9, 2C19, 2D6 vai 3A4 inhibitors.
Icelandic: In vitro rannsóknir sýna að caspófúngín er ekki hemill fyrir cýtókróm P450 ensímin 1A2, 2A6, 2C9, 2C19, 2D6 eða 3A4.
Latvian: Jutīguma pārbaudes veica, izmantojot Klīnisko un Laboratoriju Standartu Institūta (Clinical and Laboratory Standards Institute -CLSI, iepriekš pazīstamu kā Nacionālās Klīnisko Laboratoriju Standartu komiteja [NCCLS]) metodes M38-A2 (Aspergillus ģints) un M27-A3 metodes (Candida ģints) modifikācijas.
Icelandic: Næmispróf var gert samkvæmt breyttu NCCLS-prófi (Clinical and Laboratory Standards Institute (CLSI) fyrrum þekkt sem the National Committee for Clinical Laboratory Standards method) M38-A2 (fyrir Aspergillus tegundir) og prófi M27-A3 (fyrir Candida tegundir).
Latvian: Ja Jums liekas, ka Jums varētu būt ievadīts pārāk daudz Cancidas, nekavējoties pastāstiet to ārstam vai medmāsai.
Icelandic: Ef þú hefur áhyggjur af því að þér hafi verið gefið of mikið Cancidas skaltu tafarlaust segja lækninum eða hjúkrunarfræðingnum frá því.
Latvian: Piezīmes par pagatavošanu:
Icelandic: Undirbúnings minnispunktar:
Latvian: Pamatojoties uz šo pētījumu, ieteikumus par devu jaundzimušajiem un zīdaiņiem nav iespējams sniegt.
Icelandic: Á grundvelli þessarar rannsóknar er ekki hægt að gefa skammtaráðleggingar fyrir nýbura og ungbörn.
Latvian: Ir ierobežota pieredze 65 gadus vecu un vecāku pacientu ārstēšanā (skatīt 5.2. apakšpunktu).
Icelandic: Reynsla af meðferð er takmörkuð hjá 65 ára sjúklingum og eldri (sjá kafla 5.2).
Latvian: Cancidas lieto, lai ārstētu šādas infekcijas bērniem, pusaudžiem un pieaugušajiem:
Icelandic: Cancidas er notað til meðferðar við eftirtöldum sýkingum hjá börnum, unglingum og fullorðnum:
Latvian: Tas pieder pie zāļu grupas, ko sauc par pretsēnīšu zālēm.
Icelandic: Það tilheyrir lyfjaflokki sem kallast sveppalyf.
Latvian: Retāk (≥1/1 000 līdz <1/100)
Icelandic: Sjaldgæfar (≥1/1.000 til <1/100)
Latvian: Parasti ārstēšana jāturpina vismaz septiņas dienas pēc simptomu pazušanas.
Icelandic: Almennt á að halda meðferð áfram í minnst 7 daga eftir að einkenni hverfa.
Latvian: Beta (1,3)-D-glukāns nav sastopams zīdītāju šūnās.
Icelandic: Beta(1,3)-D-glúcan er ekki til staðar í spendýrafrumum.
Latvian: In vitro kaspofungīns iedarbojas uz dažādām Aspergillus ģints sugām: (Aspergillus fumigatus [N = 75], Aspergillus flavus [N = 111], Aspergillus niger [N = 31], Aspergillus nidulans [N = 8], Aspergillus terreus [N = 52]) un Aspergillus candidus [N=3]).
Icelandic: In vitro er caspófúngín virkt gegn Aspergillus tegundum (Aspergillus fumigatus [N = 75], Aspergillus flavus [N = 111], Aspergillus niger [N = 31], Aspergillus nidulans [N = 8], Aspergillus terreus [N = 52], og Aspergillus candidus [N = 3]).
Latvian: Uzmanīgi samaisiet, līdz izveidojas dzidrs šķīdums!
Icelandic: Blandið varlega þar til tær lausn fæst.
Latvian: Tad seko gamma fāze ar pusizvades periodu 45 stundas.
Icelandic: Því næst á gamma-fasi sér stað, með 45 klukkustunda helmingunartíma.